top of page

XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML

Product details

Registration number: SIN16115P

Classification: Prescription Only

Active ingredients: Omalizumab

Strength: 75mg/0.5ml

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Registrant: NOVARTIS (SINGAPORE) PTE LTD

ATC code: R03DX05

HSA approval date: 4 March 2021

Manufacturer(s):

  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Novartis Pharma Stein AG
  • Vetter Pharma-Fertigung GmbH & Co. KG (Inspection for visual defects and Secondary packager)

Manufacturing country/countries: SWITZERLAND; GERMANY

What are the HSA registration number and classification for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16115P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Omalizumab

Strength: 75mg/0.5ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Source for this answer

Who is the recorded registrant for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?

According to the HSA dataset updated 7 August 2026:

Registrant: NOVARTIS (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Novartis Pharma Stein AG
  • Vetter Pharma-Fertigung GmbH & Co. KG (Inspection for visual defects and Secondary packager)

Manufacturing country/countries: SWITZERLAND; GERMANY

Source for this answer

Where can I look up XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16115P or the exact product name XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16115P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page